Osteoporosis-whom to treat? The importance of FRAX ® in Switzerland;Osteoporose-wann behandeln? Der stellenwert von FRAX ® in der Schweiz

Therapeutische Umschau

Volumn 69, Issue 3, 2012, Pages 207-213

  Lippuner, Kurt ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID;

ALCOHOL CONSUMPTION; ALGORITHM; ARTICLE; BONE DENSITY; COMPUTER MODEL; COST EFFECTIVENESS ANALYSIS; DRUG USE; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; HUMERUS FRACTURE; OSTEOPOROSIS; PREDICTION; PROBABILITY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SECONDARY OSTEOPOROSIS; SMOKING; SPINE FRACTURE; SWITZERLAND; VALIDATION PROCESS; WRIST FRACTURE;

ALGORITHMS; COMORBIDITY; DECISION SUPPORT SYSTEMS, CLINICAL; FEMALE; FRACTURES, SPONTANEOUS; HUMANS; MALE; OSTEOPOROSIS; PATIENT SELECTION; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS;

EID: 84857945864     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930/a000275     Document Type: Article

References (15)

1. National Committee for Quality Assurance 2008. The state of health care quality. http://www.ncqa.org/tabid/858/Default.aspx. Last accessed January 13, 2012. 2008.
2. Suhm N, Lamy O, Lippuner K. Management of fragility fractures in Switzerland: results of a nationwide survey. Swiss Med Wkly 2008; 138: 674-83.
3. Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. Jama 2001; 286: 2815-22.
4. Lippuner K, Golder M, Greiner R. Epidemiology and direct medical costs of osteoporotic fractures in men and women in Switzerland. Osteoporos Int 2005;16 Suppl 2: S8-S17.
5. Lippuner K, Grifone S, Schwenkglenks M, et al. Comparative trends in hospitalizations for osteoporotic fractures and other frequent diseases between 2000 and 2008. Osteoporos Int 2011.
6. Lippuner K, Popp AW, Schwab P, et al. Fracture hospitalizations between years 2000 and 2007 in Switzerland: a trend analysis. Osteoporos Int 2011; 22: 2487-97.
7. Lippuner K, Johansson H, Kanis JA, Rizzoli R. Remaining lifetime and absolute 10-year probabilities of osteoporotic fracture in Swiss men and women. Osteoporos Int 2009; 20: 1131-40.
8. ® assessment of osteoporotic fracture probability in Switzerland. Osteoporos Int 2010; 21: 381-9.
9. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002; 359: 1929-36.
10. Kanis JA, Borgstrom F, De Laet C, et al. Assessment of fracture risk. Osteoporos Int 2005; 16: 581-9.
11. Kanis JA, Oden A, Johnell O, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007; 18: 1033-46.
12. Krieg MA, Cornuz J, Ruffieux C, et al. Prediction of hip fracture risk by quantitative ultrasound in more than 7000 Swiss women > or = 70 years of age: comparison of three technologically different bone ultrasound devices in the SEMOF study. J Bone Miner Res 2006; 21: 1457-63.
13. ® according to the dose of glucocorticoids. Osteoporos Int 2011; 22: 809-16.
14. ® enhancement. Osteoporos Int 2011; 22: 839-47.
15. ® in Switzerland. Osteoporos Int 2012 Jan 6 (Epub ahead of print).